154 related articles for article (PubMed ID: 38041175)
41. [The volume and mass growth of persisted pulmonary nodules detected in low-dose CT screening and its influence factors].
Sun Q; Huang Y; Zhao SJ; Zhang L; Tang W; Jin YJ; Wu N
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):274-279. PubMed ID: 29730914
[No Abstract] [Full Text] [Related]
42. Lymph node metastasis risk factors in clinical stage IA3 lung adenocarcinoma.
Zheng Y; Ju S; Huang R; Zhao J
J Cancer Res Ther; 2023 Feb; 19(1):34-38. PubMed ID: 37006040
[TBL] [Abstract][Full Text] [Related]
43. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
[TBL] [Abstract][Full Text] [Related]
44. Natural progression of persistent pure ground-glass nodules 10 mm or smaller: long-term observation and risk factor assessment.
He Y; Xiong Z; Tian D; Zhang J; Chen J; Li Z
Jpn J Radiol; 2023 Jun; 41(6):605-616. PubMed ID: 36607551
[TBL] [Abstract][Full Text] [Related]
45. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
[TBL] [Abstract][Full Text] [Related]
46. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
Park SY; Yoon JK; Park KJ; Lee SJ
Cancer Imaging; 2015 Dec; 15():21. PubMed ID: 26694918
[TBL] [Abstract][Full Text] [Related]
47. Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.
Rogasch JM; Apostolova I; Steffen IG; Steinkrüger FL; Genseke P; Riedel S; Wertzel H; Achenbach HJ; Kalinski T; Schultz M; Schreiber J; Amthauer H; Furth C
Eur J Radiol; 2016 Aug; 85(8):1345-50. PubMed ID: 27423672
[TBL] [Abstract][Full Text] [Related]
48. Multiparametric evaluation of mediastinal lymph node metastases in clinical T0-T1c stage non-small-cell lung cancers.
Wang S; Bao X; Yang F; Shi H
Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38429956
[TBL] [Abstract][Full Text] [Related]
49. A retrospective study of volume doubling time in surgically resected non-small cell lung cancer.
Mackintosh JA; Marshall HM; Yang IA; Bowman RV; Fong KM
Respirology; 2014 Jul; 19(5):755-62. PubMed ID: 24797504
[TBL] [Abstract][Full Text] [Related]
50. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Kaseda K; Asakura K; Kazama A; Ozawa Y
World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease.
An YS; Sun JS; Park KJ; Hwang SC; Park KJ; Sheen SS; Lee S; Lee KB; Yoon JK
Lung; 2008; 186(5):327-36. PubMed ID: 18670805
[TBL] [Abstract][Full Text] [Related]
52. The correlation of SUVmax with pathological characteristics of primary tumor and the value of Tumor/ Lymph node SUVmax ratio for predicting metastasis to lymph nodes in resected NSCLC patients.
Koksal D; Demirag F; Bayiz H; Ozmen O; Tatci E; Berktas B; Aydoğdu K; Yekeler E
J Cardiothorac Surg; 2013 Apr; 8():63. PubMed ID: 23557204
[TBL] [Abstract][Full Text] [Related]
53. Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3 cm or smaller.
Hung JJ; Yeh YC; Jeng WJ; Wu YC; Chou TY; Hsu WH
Eur J Cardiothorac Surg; 2016 Aug; 50(2):329-36. PubMed ID: 26819290
[TBL] [Abstract][Full Text] [Related]
54. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
[TBL] [Abstract][Full Text] [Related]
55. [HRCT features differentiate synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases].
Zhou LN; Wu N; Zhao SJ; Yang L; Wang YL; Wang RB; Yang SX
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):449-455. PubMed ID: 32575939
[No Abstract] [Full Text] [Related]
56. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
[TBL] [Abstract][Full Text] [Related]
57. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
[TBL] [Abstract][Full Text] [Related]
58. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
Yip R; Henschke CI; Xu DM; Li K; Jirapatnakul A; Yankelevitz DF
AJR Am J Roentgenol; 2017 May; 208(5):1011-1021. PubMed ID: 28245151
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors of lung adenocarcinoma manifesting as ground glass nodules larger than 3 cm.
Ding H; Wang H; Zhang P; Song N; Chen L; Jiang G
Eur J Cardiothorac Surg; 2019 Jun; 55(6):1130-1135. PubMed ID: 30561606
[TBL] [Abstract][Full Text] [Related]
60. [Multivariate Analysis of Solid Pulmonary Nodules Smaller than 1 cm in
Distinguishing Lung Cancer from Intrapulmonary Lymph Nodes].
Tang J; Liu C; Wang P; Cui Y
Zhongguo Fei Ai Za Zhi; 2021 Feb; 24(2):94-98. PubMed ID: 33508896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
